Life Sciences

IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery


Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer. Pfizer is one of the first organizations worldwide to deploy Watson for Drug Discovery, and the first to customize the cloud-based cognitive tool – tapping into Watson’s machine learning, natural language processing, and other cognitive reasoning technologies to support the identification of new drug targets, combination therapies for study, and patient selection strategies in immuno-oncology.

Share this post:

More Life Sciences Stories

IBM Explorys Offerings for Life Sciences

Partnering rich and timely healthcare big data with advanced technology can unlock a wealth of insights, empowering life sciences professionals to make informed decisions with efficiency and confidence.

Continue reading

Transforming Life Sciences – From Possibility to Positivity

Almost exactly 2 years ago at HIMSS we announced Watson Health, a separate business unit within IBM, focused on impacting health through the power of cognitive and analytics. Two years ago the announcement was full of possibility. Today we can share positivity, and evidence of success. In forming Watson Health we created a technology platform […]

Continue reading

Watson Health Stories: Celgene

Learn how Watson Health & Celgene are working to uncover new approaches to patient safety. Ed Mingle, the global head of Safety Operations at Celgene corporation, discusses how the possibilities of future care are endless with the power of cognitive solutions.

Continue reading